Skip to Main Content

Paper Details

TRIAMF: A New Method for Delivery of Cas9 Ribonucleoprotein Complex to Human Hematopoietic Stem Cells.
Sci Rep
27
2018
-hemoglobinopathies, CRISPR, Cas9, Cas9 Ribonucleoprotein Complex, Cas9 protein, HSPCs, Human, Human Hematopoietic Stem Cells, RNP, RNPs, TRIAMF, cell, guide RNA, hemoglobinopathies, mice, monogenic blood disorders, patient, patient-derived hematopoietic stem and progenitor cells
Author NameAffiliation
Jonathan YenNovartis Institutes for BioMedical Research
Heath E KlockThe Genomics Institute of the Novartis Research Foundation
Ning GuoNovartis Institutes for BioMedical Research
Carsten RussNovartis Institutes for BioMedical Research
  • 1 - 4

Datasets

Release 1.2